Who Owns Edesa Biotech Stock?
NASDAQ: EDSAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
After hours: 3.41 -2.85%
Ownership breakdown
- Held by institutions
- 37.44%
- Held by insiders
- 13.50%
- Institutional holders
- 39
- Institutions 37.4%
- Insiders 13.5%
- Public and other 49.1%
Who owns Edesa Biotech stock?
Institutional investors own about 37.4% of Edesa Biotech's shares, spread across 39 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 13.50% of EDSA.
The largest institutional holders are Velan Capital Investment Management LP (8.58%), Rubric Capital Management LP (6.94%) and Perceptive Advisors Llc (5.84%). Together, the top 10 institutions control 36.9% of shares outstanding. In their latest filings, 5 of the top 10 institutions increased their EDSA positions and 3 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of EDSA
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Velan Capital Investment Management LP | 827.50K | 8.58% | 0.0% |
| Rubric Capital Management LP | 669.50K | 6.94% | -2.6% |
| Perceptive Advisors Llc | 563.24K | 5.84% | 0.0% |
| Millennium Management Llc | 561.75K | 5.83% | +100.0% |
| Stonepine Capital Management, LLC | 456.44K | 4.73% | +1421.5% |
| Boxer Capital Management, LLC | 205.00K | 2.13% | +100.0% |
| Vanguard Capital Management LLC | 81.84K | 0.85% | -4.8% |
| Geode Capital Management, LLC | 80.88K | 0.84% | +5.0% |
| Jane Street Group, LLC | 72.47K | 0.75% | -37.4% |
| Vanguard Fiduciary Trust Co | 38.72K | 0.40% | +0.7% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of EDSA
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 70.44K | 0.73% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 35.41K | 0.37% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 13.54K | 0.14% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 9.60K | 0.10% |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 5.38K | 0.06% |
| Blackstone Alternative Investment Fd.s-Blackstone Alternative Multi-St | 30 | 0.00% |
Frequently asked questions
Who is the largest shareholder of Edesa Biotech?
Velan Capital Investment Management LP is the largest institutional shareholder of EDSA, owning 8.58% of shares outstanding (827.50K shares) as of its latest 13F filing.
What percentage of Edesa Biotech is owned by institutions?
Institutions own about 37.4% of EDSA shares and 43.3% of the public float.
How much of Edesa Biotech do insiders own?
Insiders, such as officers and directors, own about 13.50% of EDSA shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.